Chong Kun Dang, Hanmi disclose research results to EU scholars
IndustrySept 19, 2019
South Korea’s Chong Kun Dang and Hanmi Pharmaceutical said Thursday they presented their research results of novel diabetes treatments at the 2019 European Association for the Study of Diabetes held in Barcelona, Spain.At the 55th annual event held from Monday through Friday, Chong Kun Dang reported the efficacy of its thiazolidinedione type diabetes treatment Duvie for patients with insulin resistance syndrome. It is the 20th in the list of novel drugs developed in Korea and was commercia